Received Mar 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
Swelling on her face; Red cheeks; Pressure on the left eye; This non-serious case was reported by a other health professional via call center representative and described the occurrence of facial swelling in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced facial swelling (Verbatim: Swelling on her face), red face (Verbatim: Red cheeks) and sensation of pressure in eye (Verbatim: Pressure on the left eye). The patient was treated with diphenhydramine hydrochloride (Benadryl). The outcome of the facial swelling, red face and sensation of pressure in eye were resolved (duration 12 hrs). It was unknown if the reporter considered the facial swelling, red face and sensation of pressure in eye to be related to Shingrix. It was unknown if the company considered the facial swelling, red face and sensation of pressure in eye to be related to Shingrix. Additional Information: GSK Receipt Date: 14-MAR-2025 The reporter reported that he/she had a patient, after her 1st shot, she got swelling on her face, red cheeks and pressure on her left eye, which only lasted 12 hours, and she took Benadryl. Could she get the 2nd dose or not.